ARTICLE | Company News
F-star Biotechnology, Denali Therapeutics deal
September 5, 2016 7:00 AM UTC
Denali will use Modular Antibody Technology from F-star’s F-star Gamma Ltd. vehicle to generate Fcabs, which are Fc-domains that can bind to antigens. The Fcabs can be used to create bispecific mAbs t...